Magle Chemoswed Holding AB Logo

Magle Chemoswed Holding AB

A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.

MAGLE | ST

Overview

Corporate Details

ISIN(s):
SE0014401014 (+2 more)
LEI:
549300FNJZS6NGFB6M31
Country:
Sweden
Address:
Agneslundsvägen 27, 212 15 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Magle Chemoswed Holding AB is a contract development and manufacturing organization (CDMO) that serves companies in the pharmaceutical and medical device industries. The company offers a comprehensive suite of services that guide innovations from idea to finished product. Core capabilities include analytical and process development, solid-state chemistry, and specialized manufacturing. Its manufacturing services are performed in a cGMP and ISO 13485 compliant facility and include lyophilization (freeze-drying), flexible small-scale vial filling and finishing, and support for inhalation drug delivery systems. Magle Chemoswed partners with clients to provide end-to-end support for product development and manufacturing on a contract basis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Magle Chemoswed Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Magle Chemoswed Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Magle Chemoswed Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-21 Stig Lökke Pedersen Other Other 384,000 11,520,000.00 SEK
2024-12-11 Martin Lidgard Other Buy 4,211 136,436.40 SEK
2024-12-05 Martin Lidgard Other Buy 632 21,740.80 SEK
2024-12-02 Martin Lidgard Other Buy 5,000 163,900.00 SEK

Peer Companies

Company Country Ticker View
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America ABP
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America ACAD
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America ACRS
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America ATNM

Talk to a Data Expert

Have a question? We'll get back to you promptly.